AIC
BIOL

AWM Investment Company’s Biolase, Inc. BIOL Stock Holding History

AWM Investment Company’s Portfolio BIOL Stock Details BIOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-19,386
Closed -$545K – 124
2023
Q1 		$545K Buy
+19,386
New +$944K 0.07% 103
2015
Q2 		– Sell
-5
Closed -$129K – 136
2015
Q1 		$129K Buy
+5
New +$142K 0.02% 131

Other funds holding BIOL

Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
APP
Avantax Planning Partners Dubuque, Iowa $4.02B AUM 20% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ZF
Zhang Financial Portage, Michigan $3.42B AUM 23.04% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

AWM Investment Company's BIOL Position: Q2 2023 in Review

AWM Investment Company sold out of Biolase, Inc. (BIOL) in Q2 2023, closing a stake of 19,386 shares — an estimated $545K sold.

AWM Investment Company first reported a position in BIOL in Q1 2015 and held it in 2 quarters. The position peaked at $545K in Q1 2023. 25 funds tracked by Wall St. Rank hold BIOL as of Q2 2023.

  • AWM Investment Company reported no remaining Biolase, Inc. position as of Q2 2023 after selling out during the quarter.
  • AWM Investment Company sold 19,386 Biolase, Inc. shares in Q2 2023, an estimated $545K.
  • AWM Investment Company first reported a position in Biolase, Inc. in Q1 2015 and held it in 2 quarters.
  • AWM Investment Company's Biolase, Inc. position peaked at $545K in Q1 2023.
  • 25 funds tracked by Wall St. Rank held Biolase, Inc. as of Q2 2023.

Based on AWM Investment Company's 13F filing for Q2 2023, filed 11 Aug 2023.